Loading…
← CockpitCompetitor Analysis › JWEL.TO Jamieson Wellness, Inc.Open in the cockpit ↗

Jamieson Wellness, Inc.JWEL.TOCompetitor analysis, valuation and peers

Canada · CAD·Health Care›Pharmaceuticals: Other

Makes and markets vitamins, minerals and supplements under the Jamieson brand, sold in Canada and abroad.

Momentum leader 86
Mkt cap
$1.32B
US dollars, full cap
Free float
99%
of shares outstanding
$/day
$8.93M
20-day average traded
Fwd P/E
20.6×
forward earnings
ROIC−WACC
+0.6 pp
WACC 7.7%
Hurdle
-2 pp
Req g minus delivered
Next earnings
99 days
25 Feb 2027
Close · CADC$45.70
1D0.0%
1W+0.1%
1M+0.5%
3M-0.1%
6M+31.5%
YTD+35.8%
1Y+30.9%
ATR %0.2%
52w lowhigh0.4% off high

What Jamieson Wellness does

Makes and markets vitamins, minerals and supplements under the Jamieson brand, sold in Canada and abroad.

Owns its manufacturing in Canada, which lets it make branded products, private-label products for retailers and contract orders on the same plants, and sells branded products across grocery, drug and club stores. China is served through cross-border online channels and distributors. It bought Youtheory in 2019.

Products and services

  • Jamieson-branded VMS
  • Contract manufacturing (private label)
  • International brands (Youtheory, Precision)

Customers

  • Grocery/pharmacy retailers
  • Direct-to-consumer / e-commerce
  • International distributors (esp. China)

Where it sits in the supply chain

  • Consumer health
  • Vitamins & supplements manufacturing
  • Branded VMS + contract manufacturing

What could go right

  • Growing global wellness/supplement demand
  • Export growth into Asia

What could go wrong

  • Input-cost inflation for raw materials
  • Competitive/private-label pressure at retail

Moat: narrow (brand, distribution). Jamieson is Canada's best-known VMS brand with strong retail shelf space and export relationships.

Headquarters: Toronto, Canada · Founded: 1922 · Employees: 1,346

Named competitors

  • Nature's Bounty (Nestle Health Science) private or unlisted
  • GNC private or unlisted
  • Church & Dwight CHD
  • By-Health 300146.SZ

Jamieson Wellness at a glance

Size Jamieson Wellness (JWEL.TO) is a Canada Health Care company (Pharmaceuticals: Other) with a market value of $1.32B, the 212th largest of 405 Canada companies the cockpit tracks. Shares closed at C$45.70 on 18 Nov 2026.

Performance Over six months the shares gained 31.5%, against -8.1% for the median peer and +1.1% for the Canada market (cap-weighted) — 4th highest of 21 in its peer set.

Growth Revenue grew 12.1% over the last twelve months (peer median +9.8%); the operating margin is 13.3% (peer median 16.4%).

Valuation It trades at 20.6× forward earnings against a peer median of 16.5× (9th most expensive of 18).

Price implies For today's price to make sense, revenue must grow about 14% a year for seven years (Req g). Recent delivered growth is +15%, so the hurdle is -2 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 0.6 points above its cost of capital (7.7% WACC).

Next results Next results expected around 25 Feb 2027 (exchange calendar; dates can move).

Relative performance

10012021 May 202621 Aug 202618 Nov 2026JWEL.TO 130Peer median 90
Six months, rebased to 100: Jamieson Wellness against the median of its 20 peers (local-currency closes).

Jamieson Wellness financials

Reported figures in CAD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueC$885MC$822MC$734MC$676MC$547M
Revenue growth—+12%+9%+24%—
Gross profitC$371MC$338MC$276MC$234MC$198M
EBITDAC$139MC$133MC$112MC$108MC$101M
Net incomeC$69.9MC$62.4MC$51.9MC$47.9MC$52.8M
Free cash flowC$22.6MC$69.8MC$52.4MC$22.9MC$36.7M
Capital expenditureC$12.4MC$13.6MC$10.2MC$9.31MC$14.6M
Total debtC$495MC$445MC$427MC$460MC$467M

Quarterly statements and history in the cockpit →

Jamieson Wellness competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+50%0%+20%6472BIOG-BPHMSUDEEPPHRMCRON60021621420022870022753003630719APN002219600056PHN0460603262GRANULES1112JWEL.TO6-month return →1-month return →
Up and to the right = strong over both horizons. Jamieson Wellness is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%+60%0×100×6472BIOG-BPHMSUDEEPPHRMCRON6002162142002275APN002219PHN0460603262GRANULES1112600750JWEL.TORevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Jamieson Wellness is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%+60%0%20%40%60%6472BIOG-BPHMCRON6002162142002287002275APN600056PHN603262GRANULES600750JWEL.TOGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Jamieson Wellness is the large dot.

Jamieson Wellness competitors and peer comparison

Head to head with its named competitors (JWEL.TO vs CHD vs 300146.SZ)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Jamieson Wellness JWEL.TO$1.32B+32%+12%13%20.6×13.5%
Church & Dwight CHD$26.4B+16%+2%18%28.1×7.7%
By-health 300146.SZ$2.56B-1%+10%11%24.7×4.8%

How Jamieson Wellness compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Jamieson Wellness against its 20 peers (data as of 18 Nov 2026)
MeasureJWEL.TOPeer medianRank in peer set
1-month return+0.5%-2.3%9th highest of 21
6-month return+31.5%-8.1%4th highest of 21
Distance from 52-week high-0.4%-29.8%highest of 21
Revenue growth (TTM)+12.1%+9.8%11th highest of 21
Operating margin13.3%16.4%7th lowest of 21
Forward P/E20.6×16.5×9th most expensive of 18
Growth the price implies (Req g, 7 yrs)13.5%2.1%5th most demanding of 18
Growth delivered (Del g)+15.3%+10.6%7th highest of 18
Hurdle (Req g minus delivered)-1.8 pp-11.7 pp5th most demanding of 18
ROIC minus cost of capital+0.6 pp+3.7 pp6th lowest of 21
EV / EBITDA17.3×17.4×6th cheapest of 12
Net debt / EBITDA3.3×-0.3×2nd most indebted of 12

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Jamieson Wellness JWEL.TOCanada$1.32B+32%+12%13%20.6×13.5%+15.3%
Bora Pharmaceuticals 6472.TWTaiwan$1.25B-2%+7%14%10.8×3.5%+60.2%
BioGaia BIOG-B.STSweden$1.25B-4%+13%28%31.0×1.5%+15.5%
Pharma Mar PHM.MCSpain$1.21B-38%+32%19%41.4×10.6%-3.9%
Sudeep Pharma SUDEEPPHRM.NSIndia$1.45B+85%+27%33%69.1×n/an/a
Cronos CRON.TOCanada$1.17B+24%+55%5%16.2×18.8%+26.7%
Zhejiang Medicine 600216.SSChina$1.51B-26%-6%7%11.5×-7.8%+3.9%
HBM 2142.HKHong Kong$1.12B-18%+55%44%11.7×13.1%+62.3%
Tibet Cheezheng Tibetan Medicine 002287.SZChina$1.58B-17%-7%28%n/a-1.9%+10.4%
Guilin Sanjin Pharmaceutical 002275.SZChina$1.05B-12%-3%24%12.8×-8.7%+5.5%
Porton Pharma Solutions 300363.SZChina$1.66B+37%+6%-2%n/a2.1%+10.4%
Shandong Xinhua Pharmaceutical 0719.HKHong Kong$1.03B-19%-1%4%6.2×-2.1%+7.1%
Applied Nutrition APN.LUnited Kingdom$986M+31%+51%25%21.4×24.6%+38.5%
New Journey Health Technology Group Co., Ltd.Class A 002219.SZChina$942M-18%-14%8%182.0×n/an/a
China Meheco 600056.SSChina$1.90B-16%+2%3%n/a-1.3%-2.1%
PharmaNutra PHN.MIItaly$922M+2%+17%22%33.5×4.7%+18.5%
Sihuan Pharmaceutical 0460.HKHong Kong$856M-34%+30%15%8.7×n/an/a
TSI 603262.SSChina$842M-46%+3%14%47.7×24.3%+13.4%
Granules India GRANULES.NSIndia$2.12B+4%+22%17%24.8×23.6%+10.6%
Health and Happiness (H&H) International 1112.HKHong Kong$2.15B+108%+24%16%13.2×-1.7%+4.4%
China Resources Jiangzhong Pharmaceutical 600750.SSChina$2.27B+4%-10%24%16.5×-1.9%+11.6%

Questions

Who are Jamieson Wellness's main competitors?
Named competitors: Nature's Bounty (Nestle Health Science) (private or unlisted), GNC (private or unlisted), Church & Dwight (CHD), By-Health (300146.SZ). The cockpit's measured peer set (industry) also includes Bora Pharmaceuticals (6472.TW), BioGaia (BIOG-B.ST), Pharma Mar (PHM.MC), Sudeep Pharma (SUDEEPPHRM.NS), Cronos (CRON.TO), Zhejiang Medicine (600216.SS).
Is Jamieson Wellness expensive compared with its peers?
On forward p/e it trades at 20.6× against a peer median of 16.5×, 9th most expensive of 18 in its peer set. For today's price to make sense, revenue must grow about 14% a year for seven years (Req g). Recent delivered growth is +15%, so the hurdle is -2 pp: the price already allows for a slowdown.
How has Jamieson Wellness stock performed?
Over six months to 18 Nov 2026 the shares returned +31.5% against -8.1% for the median peer; over one year +30.9%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.